Could Calcineurin Inhibitor-Driven Sodium-Chloride Cotransporter Activation Explain Blunted Natriuresis with SGLT2 Inhibition in Kidney Transplant Recipients?

Article B Peer reviewed Small trial

Key takeaways

A study of GLP-1 RA use in patients with kidney disease: no difference in cardiovascular or renal outcomes. This group had-stage 3 CKD patients.

Tomar VB · Derici U

Article · PubMed, the drug frontier · 2026 Aug 12
https://pubmed.ncbi.nlm.nih.gov/42584943/